December 05, 2025 21:00 ET | Source: Cerevance, Inc. Phase 2 results selected as one of only 10 featured presentations…
Results were presented at the Transcatheter Cardiovascular Therapeutics (TCT) Conference 2025 in San Francisco on October 27, 2025 DynamX® bioadaptor…
Study data also showed prolonged progression-free survival with 177Lu-edotreotide compared to everolimus across patient subgroups Berlin, Germany, October 18, 2025…
PHNOM PENH, Cambodia, Sept. 18, 2025 /PRNewswire/ -- Under the joint guidance of the People's Bank of China and the National…
- The agreement includes Wealthspire Advisors, Fiducient Advisors, Newport Private Wealth and related platforms - Transaction reinforces Aon's focus on core…
V-DIFFERENCE is first study to show that Leqvio prioritized after statins helps more patients achieve guideline low-density lipoprotein cholesterol (LDL-C)…
WARREN, N.J., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced an…
BERLIN, July 14, 2025 /PRNewswire/ -- A newly published Total Economic Impact™ (TEI) study by Forrester Consulting shows a 411%…
NEW DELHI, June 6, 2025 /PRNewswire/ -- The World Health Organization (WHO) is facing intense scrutiny following the approval of…
Achieves Milestone of Planting 100,000 Trees BENGALURU, India, June 5, 2025 /PRNewswire/ -- Marriott India proudly achieved its ambitious goal…